HIMS - Him & Hers down 6% following report on 'shady supplier' for weight loss drug
2024-06-27 09:36:33 ET
More on Hims & Hers Health
- Hims & Hers: Buy The Dip To Catch The Next Rip
- Hims & Hers: The Undervalued Gem Poised For Growth
- Hims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks Ahead
- Hims & Hers defended at BofA as Lilly fights compounded GLP-1s
- Hims & Hers cut to Neutral at Citi on recent rally